SCHEMBL6789003

SCHEMBL6789003

CC(C)CC(c1ccc(Cl)cc1)N1CCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 7/20 0.48
LMNA P02545 4/20 0.45
P2RX7 Q99572 1/20 0.44
THRB P10828 2/20 0.43
POLB P06746 1/20 0.43
SLC6A2 P23975 5/20 0.42
SLC6A3 Q01959 5/20 0.42
SLC6A4 P31645 4/20 0.42
KMT2A Q03164 1/20 0.42
MC4R P32245 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CHRM2 P08172 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
CHRM1 P11229 1/20 0.41
DRD1 P21728 1/20 0.41
TBXA2R P21731 1/20 0.41
ADRA1A P35348 1/20 0.41
OPRM1 P35372 1/20 0.41
DRD3 P35462 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16982014 0.89 CYP1A2 (0.42) TP53LMNASLC6A2SLC6A3SLC6A4
SCHEMBL19368263 0.81 CYP1A2 (0.62) LMNAKMT2AMC4RALDH1A1OPRM1
SCHEMBL16461973 0.79 RPS6KB1 (0.50) TP53LMNAP2RX7THRBPOLB
SCHEMBL28751840 0.79 TP53 (0.50) TP53LMNAP2RX7THRBPOLB
SCHEMBL3669763 0.77 RPS6KB1 (0.49) TP53LMNAP2RX7THRBPOLB
SCHEMBL16461381 0.75 RPS6KB1 (0.50) TP53LMNAP2RX7THRBSLC6A2
SCHEMBL4731651 0.75 TP53 (0.47) TP53LMNAP2RX7THRBPOLB
SCHEMBL22206739 0.74 CHRM2 (0.57) TP53LMNASLC6A2SLC6A3SLC6A4
SCHEMBL22206767 0.74 CHRM2 (0.57) TP53LMNASLC6A2SLC6A3SLC6A4
SCHEMBL8716792 0.70 ADRB2 (0.48) TP53LMNASLC6A2SLC6A3SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120122834-A1 SMALL MOLECULE CD4 MIMETICS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122834-A1 SMALL MOLECULE CD4 MIMETICS AND USES THEREOF CD4, CCR1, RORC TP53 1569/4885LMNA 3342/4885P2RX7 461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.